
Fusion Antibodies PLC
LSE:FAB

Operating Margin
According to
Fusion Antibodies PLC's
latest financial reports the company's operating margin is -46%.
Operating Margin History
Statistics
Operating Margin
1 Year | 3 Years | 5 Years | |
---|---|---|---|
Average | -33.9% | -31.6% | -39.2% |
Median | -28.4% | -28.4% | -29.2% |
Min | -45.8% | -45.8% | -75.2% |
Max | -27.6% | -24.9% | -24.9% |
History Chart
Operating Margin
Operating Margin Distribution
Operating Margin Distribution
Life Sciences Tools & Services Industry
Operating Margin Across Competitors
Operating Margin Comparison
Fusion Antibodies PLC Competitors
Country | UK |
Market Cap | 1.6M GBP |
Operating Margin |
-46%
|
Country | US |
Market Cap | 198B USD |
Operating Margin |
17%
|
Country | US |
Market Cap | 166B USD |
Operating Margin |
27%
|
Country | CH |
Market Cap | 42.3B CHF |
Operating Margin |
25%
|
Country | KR |
Market Cap | 55.5T KRW |
Operating Margin |
31%
|
Country | US |
Market Cap | 36.8B USD |
Operating Margin |
13%
|
Country | US |
Market Cap | 34.7B USD |
Operating Margin |
24%
|
Country | US |
Market Cap | 30.7B USD |
Operating Margin |
2%
|
Country | US |
Market Cap | 29B USD |
Operating Margin |
29%
|
Country | CN |
Market Cap | 192B CNY |
Operating Margin |
24%
|
Country | US |
Market Cap | 25B USD |
Operating Margin |
25%
|
Profitability Report
View the profitability report to see the full profitability analysis for Fusion Antibodies PLC.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.